Patents by Inventor Charles David Nichols

Charles David Nichols has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and methods for treating ocular pathologies
    Patent number: 11759438
    Abstract: This invention features compositions, methods, and kits for treating conditions associated with pathological ocular neovascularization, reducing scarring in the eye, treating dry eye, treating macular degeneration, and treating keratitis by administering a serotonin receptor agonist.
    Type: Grant
    Filed: May 1, 2018
    Date of Patent: September 19, 2023
    Assignee: The Board of Supervisors of Louisiana State
    Inventors: Timothy Paul Foster, Charles David Nichols
  • COMPOSITIONS AND METHODS TO REDUCE PATHOGENESIS
    Publication number: 20230277503
    Abstract: This invention is directed to compositions, methods and kits for ameliorating or reducing pathogenesis of a disease by administering to a subject a serotonin receptor agonist.
    Type: Application
    Filed: November 9, 2022
    Publication date: September 7, 2023
    Inventors: Timothy Paul Foster, Charles David Nichols
  • COMPOSITIONS AND METHODS FOR TREATING OCULAR PATHOLOGIES
    Publication number: 20200330405
    Abstract: This invention features compositions, methods, and kits for treating conditions associated with pathological ocular neovascularization, reducing scarring in the eye, treating dry eye, treating macular degeneration, and treating keratitis by administering a serotonin receptor agonist.
    Type: Application
    Filed: May 1, 2018
    Publication date: October 22, 2020
    Applicant: The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College
    Inventors: Timothy Paul Foster, Charles David Nichols
  • COMPOSITIONS AND METHODS TO REDUCE PATHOGENESIS
    Publication number: 20200078335
    Abstract: This invention is directed to compositions, methods and kits for ameliorating or reducing pathogenesis of a disease by administering to a subject a serotonin receptor agonist.
    Type: Application
    Filed: May 1, 2018
    Publication date: March 12, 2020
    Inventors: Timothy Paul Foster, Charles David Nichols